• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估[F-18]MK6240正电子发射断层显像(PET)扫描中脑外非靶向结合在早期阿尔茨海默病中的作用。

Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer's disease.

作者信息

McVea Andrew, DiFilippo Alexandra, McLachlan Max J, Zammit Matthew D, Bendlin Barbara, Johnson Sterling C, Betthauser Tobey J, Christian Bradley T

机构信息

Department of Medical Physics, University of Wisconsin - Madison School of Public Health, Madison, WI, United States.

Waisman Laboratory for Brain Imaging and Behavior, Center University of Wisconsin - Madison School of Public Health, Madison, WI, United States.

出版信息

Imaging Neurosci (Camb). 2024 Apr 18;2. doi: 10.1162/imag_a_00135. eCollection 2024.

DOI:10.1162/imag_a_00135
PMID:40800261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12247575/
Abstract

[F-18]MK6240 is a Positron Emission Tomography (PET) radioligand with favorable imaging characteristics for measuring tau aggregation in Alzheimer's disease (AD). In this study, we investigated the impact of extra-cerebral off-target binding (ECB) in the meninges and sinus present in [F-18]MK6240 PET scans on quantifying tau burden in preclinical AD. Based on large cohort data from 433 [F-18]MK6240 scans acquired at the University of Wisconsin-Madison, simulations were conducted to examine the range of effects of ECB by varying the ECB profile and input radiotracer concentration curves on areas of early tau accumulation in AD. The range and patterning of ECB in the imaging cohort had high variability between participants; however, 35% revealed moderate to high meningeal signal that could influence quantification. Partial volume effects, which can lead to measured PET signal from neighboring regions influencing signal in adjacent areas of interest, were examined in the simulated images. The simulations demonstrate that signal from the sinus increases the neighboring entorhinal cortex region (ERC) signal and activity detected from the meninges can similarly influence the inferior cerebellar grey matter reference region. ECB effects from the sinus were the most prevalent in our cohort, and simulations with the average ECB profile had ERC uptake (SUV) 23% higher than simulations with no ECB. Spill-in effects from the sinus, which increases the medial and ventral temporal cortex standardized uptake value ratio (SUVR), and spill-in from the meninges into the cerebellar reference region, which leads to a reduction in global SUVR, act in opposite directions, complicating the interpretation of the derived SUVR of [F-18]MK6240 images. These simulation results quantify the effects of ECB in [F-18]MK6240 scans and introduce correction factors to minimize bias of the SUVR measure.

摘要

[F-18]MK6240是一种正电子发射断层扫描(PET)放射性配体,具有良好的成像特性,可用于测量阿尔茨海默病(AD)中的tau蛋白聚集。在本研究中,我们调查了[F-18]MK6240 PET扫描中脑膜和鼻窦的脑外非靶标结合(ECB)对临床前AD中tau蛋白负担定量的影响。基于在威斯康星大学麦迪逊分校获得的433次[F-18]MK6240扫描的大型队列数据,通过改变ECB分布和输入放射性示踪剂浓度曲线,对AD早期tau蛋白积累区域的ECB效应范围进行了模拟。成像队列中ECB的范围和模式在参与者之间具有高度变异性;然而,35%的参与者显示出中度至高度的脑膜信号,这可能会影响定量。在模拟图像中检查了部分容积效应,这种效应可能导致来自相邻区域的测量PET信号影响相邻感兴趣区域的信号。模拟表明,来自鼻窦的信号增加了相邻的内嗅皮质区域(ERC)信号,而从脑膜检测到的活性同样可以影响小脑灰质下部参考区域。鼻窦的ECB效应在我们的队列中最为普遍,具有平均ECB分布的模拟中ERC摄取(SUV)比没有ECB的模拟高23%。鼻窦的溢出效应增加了内侧和腹侧颞叶皮质标准化摄取值比(SUVR),而脑膜向小脑参考区域的溢出导致整体SUVR降低,两者作用方向相反,使得[F-18]MK6240图像衍生的SUVR的解释变得复杂。这些模拟结果量化了[F-18]MK6240扫描中ECB的效应,并引入了校正因子以最小化SUVR测量的偏差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/bec06f18ad0a/imag_a_00135_fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/380cda6dc5a2/imag_a_00135_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/942a94edb363/imag_a_00135_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/a5baf559d2dd/imag_a_00135_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/9f7fd1f17e0f/imag_a_00135_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/e844b67bd3bb/imag_a_00135_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/8f4c6165cabe/imag_a_00135_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/2a6212c4d7ad/imag_a_00135_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/66fd12095ab5/imag_a_00135_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/5719fcca140c/imag_a_00135_fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/1627e82cb917/imag_a_00135_fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/efcd4e77d9b9/imag_a_00135_fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/bec06f18ad0a/imag_a_00135_fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/380cda6dc5a2/imag_a_00135_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/942a94edb363/imag_a_00135_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/a5baf559d2dd/imag_a_00135_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/9f7fd1f17e0f/imag_a_00135_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/e844b67bd3bb/imag_a_00135_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/8f4c6165cabe/imag_a_00135_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/2a6212c4d7ad/imag_a_00135_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/66fd12095ab5/imag_a_00135_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/5719fcca140c/imag_a_00135_fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/1627e82cb917/imag_a_00135_fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/efcd4e77d9b9/imag_a_00135_fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c2/12247575/bec06f18ad0a/imag_a_00135_fig12.jpg

相似文献

1
Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer's disease.评估[F-18]MK6240正电子发射断层显像(PET)扫描中脑外非靶向结合在早期阿尔茨海默病中的作用。
Imaging Neurosci (Camb). 2024 Apr 18;2. doi: 10.1162/imag_a_00135. eCollection 2024.
2
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
3
Measurement of Cerebral Perfusion Indices from the Early Phase of [F]MK6240 Dynamic Tau PET Imaging.从[F]MK6240 动态 Tau PET 成像的早期阶段测量脑灌注指数。
J Nucl Med. 2023 Jun;64(6):968-975. doi: 10.2967/jnumed.122.265072. Epub 2023 Mar 30.
4
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
5
Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [F]MK6240.使用[F]MK6240的双时间窗动态PET成像协议中Tau负荷的定量测量
J Nucl Med. 2025 Jun 26. doi: 10.2967/jnumed.125.270165.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
8
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
9
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
10
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.

本文引用的文献

1
Optimizing quantification of MK6240 tau PET in unimpaired older adults.优化未受损老年人群中 MK6240 tau PET 的定量分析。
Neuroimage. 2023 Jan;265:119761. doi: 10.1016/j.neuroimage.2022.119761. Epub 2022 Nov 28.
2
Kinetic evaluation and assessment of longitudinal changes in reference region and extracerebral [F]MK-6240 PET uptake.对参考区域和脑外 [F]MK-6240 PET 摄取的动力学评估和纵向变化评估。
J Cereb Blood Flow Metab. 2023 Apr;43(4):581-594. doi: 10.1177/0271678X221142139. Epub 2022 Nov 24.
3
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [F]MK6240 Tau PET in Target Regions.
年龄相关和非靶点滞留与靶向区域 [F]MK6240 tau PET 纵向定量的关联。
J Nucl Med. 2023 Mar;64(3):452-459. doi: 10.2967/jnumed.122.264434. Epub 2022 Nov 17.
4
Long-term test-retest of cerebral [F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients.健康对照者和遗忘型轻度认知障碍患者脑 [F]MK-6240 结合的长期测试-重测以及脑外示踪剂摄取的纵向评估。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4580-4588. doi: 10.1007/s00259-022-05907-5. Epub 2022 Jul 19.
5
Global estimates on the number of persons across the Alzheimer's disease continuum.全球范围内阿尔茨海默病患者人数的估计。
Alzheimers Dement. 2023 Feb;19(2):658-670. doi: 10.1002/alz.12694. Epub 2022 Jun 2.
6
Impact of meningeal uptake and partial volume correction techniques on [F]MK-6240 binding in aMCI patients and healthy controls.脑膜摄取和部分容积校正技术对 aMCI 患者和健康对照者[F]MK-6240 结合的影响。
J Cereb Blood Flow Metab. 2022 Jul;42(7):1236-1246. doi: 10.1177/0271678X221076023. Epub 2022 Jan 21.
7
Evaluation of [F]-JNJ-64326067-AAA tau PET tracer in humans.评估 [F]-JNJ-64326067-AAA tau PET 示踪剂在人体中的应用。
J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14.
8
Sex differences in off-target binding using tau positron emission tomography.使用tau 正电子发射断层扫描观察药物的脱靶结合的性别差异。
Neuroimage Clin. 2021;31:102708. doi: 10.1016/j.nicl.2021.102708. Epub 2021 May 29.
9
Direct Comparison of the Tau PET Tracers F-Flortaucipir and F-MK-6240 in Human Subjects.在人体受试者中 Tau PET 示踪剂 F-Flortaucipir 和 F-MK-6240 的直接比较。
J Nucl Med. 2022 Jan;63(1):108-116. doi: 10.2967/jnumed.120.254961. Epub 2021 Apr 16.
10
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.淀粉样蛋白和 tau 成像生物标志物解释从中年后期开始的认知能力下降。
Brain. 2020 Jan 1;143(1):320-335. doi: 10.1093/brain/awz378.